Behandling af respiratorisk syncytialvirus-infektioner hos immunkompromitterede hæmatologiske patienter

Translated title of the contribution: Treatment of respiratory syncytial viral infections in immunocompromised haematological patients

Søren Thorsen*, Allan Krückow Hornsleth, Bente Klarlund Pedersen, Carsten Johan Heilmann

*Corresponding author for this work
2 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) accounts for considerable morbidity among infants and elderly, that are otherwise immunocompetent. Immunocompromised haematological patients - in particular bone marrow transplant (BMT) recipients with leukopenia - are at high risk for severe, usually fatal, RSV-pneumonia. No randomized, placebo-controlled studies of aerosolized ribavirin for BMT patients with RSV-pneumonia have been conducted, or can be anticipated. We summarize existing case reports providing circumstantial evidence in favour of an active diagnostic and early therapeutic approach to these patients.

Translated title of the contributionTreatment of respiratory syncytial viral infections in immunocompromised haematological patients
Original languageDanish
JournalUgeskrift for Laeger
Volume162
Issue number35
Pages (from-to)4644-4647
Number of pages4
ISSN0041-5782
Publication statusPublished - 28 Aug 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Treatment of respiratory syncytial viral infections in immunocompromised haematological patients'. Together they form a unique fingerprint.

Cite this